Table of Content

1 Frovatriptan Market Overview
1.1 Product Overview and Scope of Frovatriptan
1.2 Frovatriptan Segment by Type
1.2.1 Global Frovatriptan Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Hospital
1.2.3 Drug Store
1.3 Frovatriptan Segment by Application
1.3.1 Frovatriptan Sales Comparison by Application: (2021-2027)
1.3.2 Menstrual Migraines
1.3.3 Migraine with Aura
1.3.4 Migraine without Aura
1.4 Global Frovatriptan Market Size Estimates and Forecasts
1.4.1 Global Frovatriptan Revenue 2016-2027
1.4.2 Global Frovatriptan Sales 2016-2027
1.4.3 Frovatriptan Market Size by Region: 2016 Versus 2021 Versus 2027

2 Frovatriptan Market Competition by Manufacturers
2.1 Global Frovatriptan Sales Market Share by Manufacturers (2016-2021)
2.2 Global Frovatriptan Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Frovatriptan Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Frovatriptan Manufacturing Sites, Area Served, Product Type
2.5 Frovatriptan Market Competitive Situation and Trends
2.5.1 Frovatriptan Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Frovatriptan Players Market Share by Revenue
2.5.3 Global Frovatriptan Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Frovatriptan Retrospective Market Scenario by Region
3.1 Global Frovatriptan Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Frovatriptan Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Frovatriptan Market Facts & Figures by Country
3.3.1 North America Frovatriptan Sales by Country
3.3.2 North America Frovatriptan Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Frovatriptan Market Facts & Figures by Country
3.4.1 Europe Frovatriptan Sales by Country
3.4.2 Europe Frovatriptan Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Frovatriptan Market Facts & Figures by Region
3.5.1 Asia Pacific Frovatriptan Sales by Region
3.5.2 Asia Pacific Frovatriptan Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Frovatriptan Market Facts & Figures by Country
3.6.1 Latin America Frovatriptan Sales by Country
3.6.2 Latin America Frovatriptan Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Frovatriptan Market Facts & Figures by Country
3.7.1 Middle East and Africa Frovatriptan Sales by Country
3.7.2 Middle East and Africa Frovatriptan Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Frovatriptan Historic Market Analysis by Type
4.1 Global Frovatriptan Sales Market Share by Type (2016-2021)
4.2 Global Frovatriptan Revenue Market Share by Type (2016-2021)
4.3 Global Frovatriptan Price by Type (2016-2021)

5 Global Frovatriptan Historic Market Analysis by Application
5.1 Global Frovatriptan Sales Market Share by Application (2016-2021)
5.2 Global Frovatriptan Revenue Market Share by Application (2016-2021)
5.3 Global Frovatriptan Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Ligand Pharmaceuticals
6.1.1 Ligand Pharmaceuticals Corporation Information
6.1.2 Ligand Pharmaceuticals Description and Business Overview
6.1.3 Ligand Pharmaceuticals Frovatriptan Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Ligand Pharmaceuticals Product Portfolio
6.1.5 Ligand Pharmaceuticals Recent Developments/Updates
6.2 Endo Pharmaceuticals
6.2.1 Endo Pharmaceuticals Corporation Information
6.2.2 Endo Pharmaceuticals Description and Business Overview
6.2.3 Endo Pharmaceuticals Frovatriptan Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Endo Pharmaceuticals Product Portfolio
6.2.5 Endo Pharmaceuticals Recent Developments/Updates
6.3 Doc Generici
6.3.1 Doc Generici Corporation Information
6.3.2 Doc Generici Description and Business Overview
6.3.3 Doc Generici Frovatriptan Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Doc Generici Product Portfolio
6.3.5 Doc Generici Recent Developments/Updates
6.4 Menarini
6.4.1 Menarini Corporation Information
6.4.2 Menarini Description and Business Overview
6.4.3 Menarini Frovatriptan Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Menarini Product Portfolio
6.4.5 Menarini Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Frovatriptan Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Novartis Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Almac
6.6.1 Almac Corporation Information
6.6.2 Almac Description and Business Overview
6.6.3 Almac Frovatriptan Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Almac Product Portfolio
6.6.5 Almac Recent Developments/Updates
6.7 Glenmark Generics
6.6.1 Glenmark Generics Corporation Information
6.6.2 Glenmark Generics Description and Business Overview
6.6.3 Glenmark Generics Frovatriptan Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Glenmark Generics Product Portfolio
6.7.5 Glenmark Generics Recent Developments/Updates
6.8 Teva
6.8.1 Teva Corporation Information
6.8.2 Teva Description and Business Overview
6.8.3 Teva Frovatriptan Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Teva Product Portfolio
6.8.5 Teva Recent Developments/Updates
6.9 Zambon
6.9.1 Zambon Corporation Information
6.9.2 Zambon Description and Business Overview
6.9.3 Zambon Frovatriptan Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Zambon Product Portfolio
6.9.5 Zambon Recent Developments/Updates
6.10 Apotex
6.10.1 Apotex Corporation Information
6.10.2 Apotex Description and Business Overview
6.10.3 Apotex Frovatriptan Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Apotex Product Portfolio
6.10.5 Apotex Recent Developments/Updates
6.11 G.L. Pharma
6.11.1 G.L. Pharma Corporation Information
6.11.2 G.L. Pharma Frovatriptan Description and Business Overview
6.11.3 G.L. Pharma Frovatriptan Sales, Revenue and Gross Margin (2016-2021)
6.11.4 G.L. Pharma Product Portfolio
6.11.5 G.L. Pharma Recent Developments/Updates
6.12 Chanelle Pharma
6.12.1 Chanelle Pharma Corporation Information
6.12.2 Chanelle Pharma Frovatriptan Description and Business Overview
6.12.3 Chanelle Pharma Frovatriptan Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Chanelle Pharma Product Portfolio
6.12.5 Chanelle Pharma Recent Developments/Updates

7 Frovatriptan Manufacturing Cost Analysis
7.1 Frovatriptan Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Frovatriptan
7.4 Frovatriptan Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Frovatriptan Distributors List
8.3 Frovatriptan Customers

9 Frovatriptan Market Dynamics
9.1 Frovatriptan Industry Trends
9.2 Frovatriptan Growth Drivers
9.3 Frovatriptan Market Challenges
9.4 Frovatriptan Market Restraints

10 Global Market Forecast
10.1 Frovatriptan Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Frovatriptan by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Frovatriptan by Type (2022-2027)
10.2 Frovatriptan Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Frovatriptan by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Frovatriptan by Application (2022-2027)
10.3 Frovatriptan Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Frovatriptan by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Frovatriptan by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Frovatriptan Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Frovatriptan Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Frovatriptan Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Frovatriptan Covered in This Study
Table 5. Global Frovatriptan Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Frovatriptan Sales Share by Manufacturers (2016-2021)
Table 7. Global Frovatriptan Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Frovatriptan Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Frovatriptan Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Frovatriptan Manufacturing Sites and Area Served
Table 11. Manufacturers Frovatriptan Product Type
Table 12. Global Frovatriptan Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Frovatriptan by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Frovatriptan as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Frovatriptan Sales by Region (2016-2021) & (K Units)
Table 16. Global Frovatriptan Sales Market Share by Region (2016-2021)
Table 17. Global Frovatriptan Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Frovatriptan Sales by Country (2016-2021) & (K Units)
Table 19. North America Frovatriptan Sales Market Share by Country (2016-2021)
Table 20. North America Frovatriptan Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Frovatriptan Revenue Market Share by Country (2016-2021)
Table 22. Europe Frovatriptan Sales by Country (2016-2021) & (K Units)
Table 23. Europe Frovatriptan Sales Market Share by Country (2016-2021)
Table 24. Europe Frovatriptan Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Frovatriptan Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Frovatriptan Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Frovatriptan Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Frovatriptan Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Frovatriptan Revenue Market Share by Region (2016-2021)
Table 30. Latin America Frovatriptan Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Frovatriptan Sales Market Share by Country (2016-2021)
Table 32. Latin America Frovatriptan Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Frovatriptan Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Frovatriptan Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Frovatriptan Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Frovatriptan Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Frovatriptan Revenue Market Share by Country (2016-2021)
Table 38. Global Frovatriptan Sales (K Units) by Type (2016-2021)
Table 39. Global Frovatriptan Sales Market Share by Type (2016-2021)
Table 40. Global Frovatriptan Revenue (Million US$) by Type (2016-2021)
Table 41. Global Frovatriptan Revenue Share by Type (2016-2021)
Table 42. Global Frovatriptan Price (US$/Unit) by Type (2016-2021)
Table 43. Global Frovatriptan Sales (K Units) by Application (2016-2021)
Table 44. Global Frovatriptan Sales Market Share by Application (2016-2021)
Table 45. Global Frovatriptan Revenue (Million US$) by Application (2016-2021)
Table 46. Global Frovatriptan Revenue Share by Application (2016-2021)
Table 47. Global Frovatriptan Price (US$/Unit) by Application (2016-2021)
Table 48. Ligand Pharmaceuticals Corporation Information
Table 49. Ligand Pharmaceuticals Description and Business Overview
Table 50. Ligand Pharmaceuticals Frovatriptan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Ligand Pharmaceuticals Frovatriptan Product
Table 52. Ligand Pharmaceuticals Recent Developments/Updates
Table 53. Endo Pharmaceuticals Corporation Information
Table 54. Endo Pharmaceuticals Description and Business Overview
Table 55. Endo Pharmaceuticals Frovatriptan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Endo Pharmaceuticals Frovatriptan Product
Table 57. Endo Pharmaceuticals Recent Developments/Updates
Table 58. Doc Generici Corporation Information
Table 59. Doc Generici Description and Business Overview
Table 60. Doc Generici Frovatriptan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Doc Generici Frovatriptan Product
Table 62. Doc Generici Recent Developments/Updates
Table 63. Menarini Corporation Information
Table 64. Menarini Description and Business Overview
Table 65. Menarini Frovatriptan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Menarini Frovatriptan Product
Table 67. Menarini Recent Developments/Updates
Table 68. Novartis Corporation Information
Table 69. Novartis Description and Business Overview
Table 70. Novartis Frovatriptan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Novartis Frovatriptan Product
Table 72. Novartis Recent Developments/Updates
Table 73. Almac Corporation Information
Table 74. Almac Description and Business Overview
Table 75. Almac Frovatriptan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Almac Frovatriptan Product
Table 77. Almac Recent Developments/Updates
Table 78. Glenmark Generics Corporation Information
Table 79. Glenmark Generics Description and Business Overview
Table 80. Glenmark Generics Frovatriptan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Glenmark Generics Frovatriptan Product
Table 82. Glenmark Generics Recent Developments/Updates
Table 83. Teva Corporation Information
Table 84. Teva Description and Business Overview
Table 85. Teva Frovatriptan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Teva Frovatriptan Product
Table 87. Teva Recent Developments/Updates
Table 88. Zambon Corporation Information
Table 89. Zambon Description and Business Overview
Table 90. Zambon Frovatriptan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Zambon Frovatriptan Product
Table 92. Zambon Recent Developments/Updates
Table 93. Apotex Corporation Information
Table 94. Apotex Description and Business Overview
Table 95. Apotex Frovatriptan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Apotex Frovatriptan Product
Table 97. Apotex Recent Developments/Updates
Table 98. G.L. Pharma Corporation Information
Table 99. G.L. Pharma Description and Business Overview
Table 100. G.L. Pharma Frovatriptan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. G.L. Pharma Frovatriptan Product
Table 102. G.L. Pharma Recent Developments/Updates
Table 103. Chanelle Pharma Corporation Information
Table 104. Chanelle Pharma Description and Business Overview
Table 105. Chanelle Pharma Frovatriptan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Chanelle Pharma Frovatriptan Product
Table 107. Chanelle Pharma Recent Developments/Updates
Table 108. Production Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Frovatriptan Distributors List
Table 111. Frovatriptan Customers List
Table 112. Frovatriptan Market Trends
Table 113. Frovatriptan Growth Drivers
Table 114. Frovatriptan Market Restraints
Table 115. Global Frovatriptan Sales Forecast by Type (2022-2027) & (K Units)
Table 116. Global Frovatriptan Sales Market Share Forecast by Type (2022-2027)
Table 117. Global Frovatriptan Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 118. Global Frovatriptan Revenue Market Share Forecast by Type (2022-2027)
Table 119. Global Frovatriptan Sales Forecast by Application (2022-2027) & (K Units)
Table 120. Global Frovatriptan Sales Market Share Forecast by Application (2022-2027)
Table 121. Global Frovatriptan Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 122. Global Frovatriptan Revenue Market Share Forecast by Application (2022-2027)
Table 123. Global Frovatriptan Sales Forecast by Region (2022-2027) & (K Units)
Table 124. Global Frovatriptan Sales Market Share Forecast by Region (2022-2027)
Table 125. Global Frovatriptan Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 126. Global Frovatriptan Revenue Market Share Forecast by Region (2022-2027)
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Frovatriptan
Figure 2. Global Frovatriptan Market Share by Type in 2020 & 2027
Figure 3. Hospital Product Picture
Figure 4. Drug Store Product Picture
Figure 5. Global Frovatriptan Market Share by Application in 2020 & 2027
Figure 6. Menstrual Migraines
Figure 7. Migraine with Aura
Figure 8. Migraine without Aura
Figure 9. Global Frovatriptan Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Frovatriptan Market Size 2016-2027 (US$ Million)
Figure 11. Global Frovatriptan Sales 2016-2027 (K Units)
Figure 12. Global Frovatriptan Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Frovatriptan Sales Share by Manufacturers in 2020
Figure 14. Global Frovatriptan Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Frovatriptan Players: Market Share by Revenue in 2020
Figure 16. Frovatriptan Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Frovatriptan Sales Market Share by Region (2016-2021)
Figure 18. Global Frovatriptan Sales Market Share by Region in 2020
Figure 19. Global Frovatriptan Revenue Market Share by Region (2016-2021)
Figure 20. Global Frovatriptan Revenue Market Share by Region in 2020
Figure 21. U.S. Frovatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Frovatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Frovatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Frovatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Frovatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Frovatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Frovatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Frovatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Frovatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Frovatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Frovatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Frovatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Frovatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Frovatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Frovatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Frovatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Frovatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Frovatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Frovatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Frovatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Frovatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Frovatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Frovatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Frovatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Frovatriptan by Type (2016-2021)
Figure 46. Sales Market Share of Frovatriptan by Application (2016-2021)
Figure 47. Sales Market Share of Frovatriptan by Application in 2020
Figure 48. Revenue Share of Frovatriptan by Application (2016-2021)
Figure 49. Revenue Share of Frovatriptan by Application in 2020
Figure 50. Manufacturing Cost Structure of Frovatriptan
Figure 51. Manufacturing Process Analysis of Frovatriptan
Figure 52. Frovatriptan Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed